ClinConnect ClinConnect Logo
Search / Trial NCT06167330

TITAN Trial: Reducing Phantom Limb Pain in People with Amputations

Launched by NEUROSCIENCE RESEARCH AUSTRALIA · Dec 7, 2023

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

ClinConnect Summary

The TITAN Trial is studying ways to reduce phantom limb pain in people who have had amputations. Phantom limb pain is when individuals feel pain in a limb that is no longer there. This trial compares two different rehabilitation programs to see which one works better at relieving this type of pain. One group will participate in a progressive rehabilitation program that includes education about pain, sensory training, and techniques like mirror therapy. The other group will use stimulation devices that deliver electrical signals to help manage pain. Both programs will take place through telehealth sessions, which means participants can join from home.

To be eligible for this trial, participants must be aged 65 to 74, have experienced phantom limb pain for at least three months, and have had pain in the past week. They should also be able to access the internet and be comfortable using smart devices. However, people with certain conditions, like bilateral amputations or major cognitive issues, cannot participate. Throughout the trial, participants will have their pain levels checked at different times to see how effective the treatments are. This research aims to find better ways to help those suffering from phantom limb pain and improve their quality of life.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Experiencing phantom limb pain for at least three months.
  • Report at least one episode of phantom limb pain in the previous week.
  • Report at least 4 points in pain intensity over the previous 7 days, assessed using the 11-point Numerical Pain Rating Scale.
  • Be a resident in Australia for the intervention and follow-up period.
  • Have access to the internet and smart device (e.g., mobile phone).
  • Be proficient in English.
  • Exclusion Criteria:
  • Bilateral amputation.
  • Scheduled for major surgery during the study period.
  • Pain in the intact limb.
  • Vision impairment that would preclude successful participation.
  • Auditory impairment that would preclude successful participation.
  • Cognitive problems that would preclude effective participation in trial procedures (e.g., Alzheimer's, dementia).
  • Previously diagnosed neurological disorders that affect the movement of the intact limb (e.g., stroke, Parkinson, Multiple Sclerosis).
  • Completed Graded Motor Imagery in the order of left/right judgements, imagined movements, and mirror therapy.
  • Have contraindications for the use of stimulation devices (e.g., pacemaker, spinal cord stimulator).

About Neuroscience Research Australia

Neuroscience Research Australia (NeuRA) is a leading independent medical research institute dedicated to advancing our understanding of the brain and nervous system. Located in Sydney, NeuRA focuses on a broad range of neurological and psychological disorders, aiming to translate scientific discoveries into real-world applications that improve patient outcomes. The institute conducts innovative clinical trials and research studies, leveraging cutting-edge technologies and interdisciplinary collaboration to drive breakthroughs in diagnosis, treatment, and prevention. With a commitment to excellence in research and a strong emphasis on community engagement, NeuRA strives to enhance the quality of life for individuals affected by neurological conditions.

Locations

Randwick, New South Wales, Australia

Patients applied

0 patients applied

Trial Officials

James H McAuley, PhD

Principal Investigator

Neuroscience Research Australia

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported